Bird Flu > Bird Flu News > Daiichi Sankyo Seeks to Sell Long-Acting Flu Drug (Update2) (Bloomberg)

Daiichi Sankyo Seeks to Sell Long-Acting Flu Drug (Update2) (Bloomberg)
Feb. 1 (Bloomberg) -- Daiichi Sankyo Co. , Japan’s third- biggest drugmaker, applied for approval to sell its novel long- acting flu drug in the country, giving patients an additional option for treatment.